Clinical Trial Update: Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zoledronate for treating bone marrow micrometastases in women with breast cancer (stages I–III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-05-12